KR20220149620A - 산소 전달을 수반 또는 비-수반하는 적층형 조직 캡슐화 장치 시스템 - Google Patents
산소 전달을 수반 또는 비-수반하는 적층형 조직 캡슐화 장치 시스템 Download PDFInfo
- Publication number
- KR20220149620A KR20220149620A KR1020227037085A KR20227037085A KR20220149620A KR 20220149620 A KR20220149620 A KR 20220149620A KR 1020227037085 A KR1020227037085 A KR 1020227037085A KR 20227037085 A KR20227037085 A KR 20227037085A KR 20220149620 A KR20220149620 A KR 20220149620A
- Authority
- KR
- South Korea
- Prior art keywords
- lumen
- lumens
- encapsulation
- encapsulation device
- cells
- Prior art date
Links
- 238000005538 encapsulation Methods 0.000 title claims abstract description 129
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 title claims abstract description 78
- 239000001301 oxygen Substances 0.000 title claims abstract description 78
- 229910052760 oxygen Inorganic materials 0.000 title claims abstract description 78
- 239000012528 membrane Substances 0.000 claims description 43
- 239000007789 gas Substances 0.000 claims description 34
- 239000011148 porous material Substances 0.000 claims description 9
- 239000012530 fluid Substances 0.000 claims description 8
- 239000003814 drug Substances 0.000 claims description 5
- 229940124597 therapeutic agent Drugs 0.000 claims description 5
- 238000000034 method Methods 0.000 claims 12
- 230000004888 barrier function Effects 0.000 claims 3
- 210000004027 cell Anatomy 0.000 abstract description 69
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 abstract description 5
- 238000002513 implantation Methods 0.000 abstract description 5
- 210000004153 islets of langerhan Anatomy 0.000 abstract description 5
- 210000000130 stem cell Anatomy 0.000 abstract description 5
- 230000001225 therapeutic effect Effects 0.000 abstract description 5
- 235000015097 nutrients Nutrition 0.000 abstract description 4
- 239000000126 substance Substances 0.000 abstract description 4
- 210000000496 pancreas Anatomy 0.000 abstract description 2
- 238000011282 treatment Methods 0.000 abstract description 2
- 230000002641 glycemic effect Effects 0.000 abstract 1
- 230000002792 vascular Effects 0.000 description 8
- 239000010410 layer Substances 0.000 description 7
- 238000010186 staining Methods 0.000 description 7
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 230000007246 mechanism Effects 0.000 description 6
- 230000001105 regulatory effect Effects 0.000 description 6
- 210000005166 vasculature Anatomy 0.000 description 6
- 210000004204 blood vessel Anatomy 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 4
- 239000002870 angiogenesis inducing agent Substances 0.000 description 4
- 238000004891 communication Methods 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 230000001023 pro-angiogenic effect Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000001574 biopsy Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000036770 blood supply Effects 0.000 description 2
- 230000001086 cytosolic effect Effects 0.000 description 2
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 238000005470 impregnation Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000004779 membrane envelope Anatomy 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 239000000565 sealant Substances 0.000 description 2
- 230000006444 vascular growth Effects 0.000 description 2
- 108010073385 Fibrin Proteins 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010080379 Fibrin Tissue Adhesive Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000001146 hypoxic effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- -1 polytetrafluoroethylene Polymers 0.000 description 1
- 239000012812 sealant material Substances 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/022—Artificial gland structures using bioreactors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0095—Packages or dispensers for prostheses or other implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0031—Implanted circuitry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14503—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/686—Permanently implanted devices, e.g. pacemakers, other stimulators, biochips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/062—Apparatus for the production of blood vessels made from natural tissue or with layers of living cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/225—Fibrin; Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0069—Devices for implanting pellets, e.g. markers or solid medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/02—Access sites
- A61M39/0208—Subcutaneous access sites for injecting or removing fluids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
- A61M5/14276—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body specially adapted for implantation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/0075—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements sutured, ligatured or stitched, retained or tied with a rope, string, thread, wire or cable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/62—Encapsulated active agents, e.g. emulsified droplets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/64—Animal cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Medical Informatics (AREA)
- Dermatology (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Surgery (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Optics & Photonics (AREA)
- Cell Biology (AREA)
- Anesthesiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Botany (AREA)
- Developmental Biology & Embryology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Dispersion Chemistry (AREA)
- Emergency Medicine (AREA)
- Computer Networks & Wireless Communication (AREA)
- Prostheses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662417017P | 2016-11-03 | 2016-11-03 | |
US62/417,017 | 2016-11-03 | ||
KR1020197015935A KR102460406B1 (ko) | 2016-11-03 | 2017-11-03 | 산소 전달을 수반 또는 비-수반하는 적층형 조직 캡슐화 장치 시스템 |
PCT/US2017/060034 WO2018144098A1 (en) | 2016-11-03 | 2017-11-03 | Stacked tissue encapsulation device systems with or without oxygen delivery |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020197015935A Division KR102460406B1 (ko) | 2016-11-03 | 2017-11-03 | 산소 전달을 수반 또는 비-수반하는 적층형 조직 캡슐화 장치 시스템 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20220149620A true KR20220149620A (ko) | 2022-11-08 |
Family
ID=63041029
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020197015935A KR102460406B1 (ko) | 2016-11-03 | 2017-11-03 | 산소 전달을 수반 또는 비-수반하는 적층형 조직 캡슐화 장치 시스템 |
KR1020227037085A KR20220149620A (ko) | 2016-11-03 | 2017-11-03 | 산소 전달을 수반 또는 비-수반하는 적층형 조직 캡슐화 장치 시스템 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020197015935A KR102460406B1 (ko) | 2016-11-03 | 2017-11-03 | 산소 전달을 수반 또는 비-수반하는 적층형 조직 캡슐화 장치 시스템 |
Country Status (7)
Country | Link |
---|---|
US (2) | US11446133B2 (zh) |
KR (2) | KR102460406B1 (zh) |
CN (2) | CN116919648A (zh) |
AU (3) | AU2017396753B2 (zh) |
CA (1) | CA3042709A1 (zh) |
SG (1) | SG10202104562TA (zh) |
WO (1) | WO2018144098A1 (zh) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG11201602232UA (en) | 2013-09-24 | 2016-04-28 | Giner Inc | System for gas treatment of a cell implant |
WO2018067813A1 (en) * | 2016-10-05 | 2018-04-12 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Methods and systems for augmenting immune system responses |
KR20190106996A (ko) | 2016-11-03 | 2019-09-18 | 아리조나 보드 오브 리전츠 온 비해프 오브 더 유니버시티 오브 아리조나 | 외부 산소 전달을 수반 또는 비-수반하는 산소 센서가 구비된 캡슐화 장치 시스템 |
SG10202104564SA (en) | 2016-11-03 | 2021-06-29 | Univ Arizona | Methods and systems for real-time assessment of cells in encapsulation devices pre-and post-transplantation |
KR102460406B1 (ko) | 2016-11-03 | 2022-10-31 | 아리조나 보드 오브 리전츠 온 비해프 오브 더 유니버시티 오브 아리조나 | 산소 전달을 수반 또는 비-수반하는 적층형 조직 캡슐화 장치 시스템 |
US10557691B2 (en) | 2016-11-15 | 2020-02-11 | Giner Life Sciences, Inc. | Self-regulating electrolytic gas generator and implant system comprising the same |
MX2019005676A (es) | 2016-11-15 | 2019-09-10 | Giner Life Sciences Inc | Dispositivo percutáneo de difusión de gases adecuado para su uso con un implante subcutáneo. |
EP3618916A4 (en) | 2017-05-04 | 2021-04-14 | Giner Life Sciences, Inc. | ROBUST IMPLANTABLE GAS DISPENSING DEVICE AND PROCEDURES, SYSTEMS AND DEVICES THEREFORE |
CA3100192C (en) | 2018-05-17 | 2023-03-14 | Giner Life Sciences, Inc. | Electrolytic gas generator with combined lead and gas port terminals |
CN113710199A (zh) * | 2019-04-03 | 2021-11-26 | 沃泰克斯药物股份有限公司 | 多隔室大胶囊装置 |
CN114641324A (zh) * | 2019-10-10 | 2022-06-17 | W.L.戈尔及同仁股份有限公司 | 细胞封装装置 |
WO2023118360A1 (en) * | 2021-12-23 | 2023-06-29 | Universiteit Maastricht | Immunoprotective type implantable cell delivery device |
Family Cites Families (69)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4902476A (en) | 1983-01-14 | 1990-02-20 | Baxter International Inc. | Heat exchanger and blood oxygenator apparatus |
US5101814A (en) | 1989-08-11 | 1992-04-07 | Palti Yoram Prof | System for monitoring and controlling blood glucose |
US5100392A (en) | 1989-12-08 | 1992-03-31 | Biosynthesis, Inc. | Implantable device for administration of drugs or other liquid solutions |
US5169390A (en) | 1990-05-21 | 1992-12-08 | Athayde Amulya L | Osmotic infusion device |
BR9106205A (pt) | 1990-10-31 | 1993-03-30 | Baxter Int | Dispositivo para implantacao em hospedeiro,processo de implantacao,dispositivo implantado,e recipiente de imunoisolamento |
US5713888A (en) | 1990-10-31 | 1998-02-03 | Baxter International, Inc. | Tissue implant systems |
DE4230194C2 (de) | 1992-09-09 | 1995-07-27 | Joerg Dr Med Gerlach | Reaktor zur Züchtung und zur Nutzung von Stoffwechselleistungen und/oder zum Erhalt von Mikroorganismen |
US6156305A (en) | 1994-07-08 | 2000-12-05 | Baxter International Inc. | Implanted tumor cells for the prevention and treatment of cancer |
US6060640A (en) | 1995-05-19 | 2000-05-09 | Baxter International Inc. | Multiple-layer, formed-in-place immunoisolation membrane structures for implantation of cells in host tissue |
HUP0101076A2 (hu) | 1998-03-02 | 2001-08-28 | Applied Vaccine Technologies Corp. | Eljárások és eszközök az immunválasz módosítására |
US6197575B1 (en) | 1998-03-18 | 2001-03-06 | Massachusetts Institute Of Technology | Vascularized perfused microtissue/micro-organ arrays |
US6143293A (en) | 1998-03-26 | 2000-11-07 | Carnegie Mellon | Assembled scaffolds for three dimensional cell culturing and tissue generation |
US6368592B1 (en) | 1998-07-17 | 2002-04-09 | Massachusetts Institute Of Technology | Method of delivering oxygen to cells by electrolyzing water |
ATE345827T1 (de) | 1999-04-23 | 2006-12-15 | Renamed Biolog Inc | Extrakorporaler kreislauf |
WO2000078920A1 (en) | 1999-06-21 | 2000-12-28 | The General Hospital Corporation | Methods and devices for cell culturing and organ assist systems |
US20030129736A1 (en) | 1999-07-15 | 2003-07-10 | Eduardo Mitrani | Device and method for performing a biological modification of a fluid |
US8012500B2 (en) * | 2000-01-01 | 2011-09-06 | Beta-O2 Technologies Ltd. | Implantable device |
IL134009A (en) | 2000-01-12 | 2011-07-31 | Bo2 Technologies Ltd | Transplant device |
CA2447763A1 (en) | 2001-06-08 | 2002-12-19 | Boehringer Ingelheim Pharmaceuticals, Inc. | Methods for improving cell line activity in immunoisolation devices |
US20030054544A1 (en) | 2001-09-14 | 2003-03-20 | Medcell Biologics, Inc. | Oxygen enriched bioreactor and method of culturing cells |
US20040197374A1 (en) | 2003-04-02 | 2004-10-07 | Alireza Rezania | Implantable pouch seeded with insulin-producing cells to treat diabetes |
JP4824549B2 (ja) | 2003-05-02 | 2011-11-30 | サーモディクス,インコーポレイティド | 制御放出型の生体活性物質デリバリー・デバイス |
WO2009048462A1 (en) | 2007-10-09 | 2009-04-16 | Dexcom, Inc. | Integrated insulin delivery system with continuous glucose sensor |
EP1765455A2 (en) | 2004-06-01 | 2007-03-28 | Microchips, Inc. | Devices and methods for measuring and enhancing drug or analyte transport to/from medical implant |
EP1761331A2 (en) | 2004-06-07 | 2007-03-14 | Bioprocessors Corporation | Control of reactor environmental conditions |
EP1875560A4 (en) | 2005-04-05 | 2011-02-09 | Univ Ohio State | DIFFUSION DELIVERY SYSTEM AND METHODS OF MAKING |
WO2007030752A2 (en) | 2005-09-09 | 2007-03-15 | University Of Arkansas At Little Rock | System and method for tissue generation and bone regeneration |
WO2008079997A2 (en) | 2006-12-22 | 2008-07-03 | Medtronic, Inc. | Implantable device, angiogenesis mechanism and methods |
US8911996B2 (en) | 2007-01-31 | 2014-12-16 | Technion Research & Development Foundation Limited | Electrospun scaffolds and methods of generating and using same |
WO2008100559A2 (en) * | 2007-02-14 | 2008-08-21 | Bioengine, Inc. | Medical devices having a micro-fluidic channeled vasculature |
US20090024147A1 (en) * | 2007-07-18 | 2009-01-22 | Ralph James D | Implantable mesh for musculoskeletal trauma, orthopedic reconstruction and soft tissue repair |
US8673294B2 (en) * | 2008-04-25 | 2014-03-18 | Vanderbilt University | Immunoisolation patch system for cellular transplantation |
EP2113261B1 (en) * | 2008-04-29 | 2013-11-06 | Proxy Biomedical Limited | A Tissue Repair Implant |
US20100119605A1 (en) | 2008-11-12 | 2010-05-13 | Isenburg Jason C | Compositions for tissue stabilization |
CN102282254B (zh) | 2008-11-14 | 2015-12-16 | 维赛特公司 | 源于人多能干细胞的胰腺细胞的包封 |
US8043271B2 (en) | 2008-11-26 | 2011-10-25 | Beta 02 Technologies Ltd. | Apparatus for transportation of oxygen to implanted cells |
US9220598B2 (en) * | 2009-02-12 | 2015-12-29 | Warsaw Orthopedic, Inc. | Delivery systems, tools, and methods of use |
TW201034641A (en) | 2009-02-28 | 2010-10-01 | Charles Knezevich | Apparatus, system, and method for creating immunologically enhanced spaces in-vivo |
GR1007310B (el) | 2009-03-09 | 2011-06-10 | Αχιλλεας Τσουκαλης | Εμφυτευσιμος βιοαισθητηρας με αυτοματη βαθμονομηση |
US20100255059A1 (en) | 2009-04-02 | 2010-10-07 | Ynano, Llc | Artificial micro-gland |
CN102012390A (zh) | 2010-11-15 | 2011-04-13 | 普林斯顿医疗科技(珠海)有限公司 | 无线多功能连续葡萄糖监测系统 |
CN203915611U (zh) | 2011-02-09 | 2014-11-05 | 贝克顿·迪金森公司 | 与输注基部附接的套节及用于传送药物的传送系统 |
WO2012115619A1 (en) | 2011-02-21 | 2012-08-30 | Viacyte, Inc. | Loading system for an encapsulation device |
AU2012364760B2 (en) | 2012-01-09 | 2018-05-31 | Seastar Medical Inc. | Cartridge and method for increasing myocardial function |
US9101707B2 (en) | 2012-04-27 | 2015-08-11 | Gregory Zeltser | Implantable bioartificial perfusion system |
KR102037150B1 (ko) | 2012-06-22 | 2019-10-28 | 지-메디카 엘엘씨 | 지혈 장치 |
WO2014008432A1 (en) | 2012-07-06 | 2014-01-09 | The Regents Of The University Of California | Cryopreservation of cells inside a macro-encapsulation device |
WO2014031666A1 (en) | 2012-08-20 | 2014-02-27 | Terumo Bct, Inc. | Method of loading and distributing cells in a bioreactor of a cell expansion system |
US20170072074A1 (en) | 2012-12-28 | 2017-03-16 | Glusense Ltd. | Implantable cell encapsulation device |
CN105163688B (zh) * | 2013-03-07 | 2018-11-20 | 韦尔赛特公司 | 三维大容量细胞包封装置组件 |
WO2014173441A1 (en) | 2013-04-24 | 2014-10-30 | Nestec S.A. | Encapsulation device |
SG11201602232UA (en) | 2013-09-24 | 2016-04-28 | Giner Inc | System for gas treatment of a cell implant |
US9861747B2 (en) | 2013-12-05 | 2018-01-09 | Lifescan, Inc. | Method and system for management of diabetes with a glucose monitor and infusion pump to provide feedback on bolus dosing |
US9950151B2 (en) | 2014-03-27 | 2018-04-24 | Beta-O2 Technologies Ltd. | Implantable medical devices |
US10149640B2 (en) | 2014-06-16 | 2018-12-11 | The Regents Of The University Of California | Measuring oxygen levels in an implant, and implants having incorporated oxygen sensing |
US9814413B2 (en) | 2014-07-24 | 2017-11-14 | Thomas Jefferson University | Long-term implantable monitoring system and methods of use |
US10190950B2 (en) | 2014-10-31 | 2019-01-29 | General Electric Company | Semi-automated sampling system for aseptic sampling |
CN109843417B (zh) | 2016-08-21 | 2022-09-02 | 艾德瓦生物技术股份有限公司 | 生物反应器及其使用方法 |
WO2018067813A1 (en) | 2016-10-05 | 2018-04-12 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Methods and systems for augmenting immune system responses |
RS60909B1 (sr) | 2016-10-19 | 2020-11-30 | Beta Cell Tech Pty Ltd | Zasejavanje ćelijske populacije u dermalne matrikse za upravljanje endokrinim poremećajem |
SG10202104564SA (en) | 2016-11-03 | 2021-06-29 | Univ Arizona | Methods and systems for real-time assessment of cells in encapsulation devices pre-and post-transplantation |
KR102460406B1 (ko) | 2016-11-03 | 2022-10-31 | 아리조나 보드 오브 리전츠 온 비해프 오브 더 유니버시티 오브 아리조나 | 산소 전달을 수반 또는 비-수반하는 적층형 조직 캡슐화 장치 시스템 |
KR20190106996A (ko) | 2016-11-03 | 2019-09-18 | 아리조나 보드 오브 리전츠 온 비해프 오브 더 유니버시티 오브 아리조나 | 외부 산소 전달을 수반 또는 비-수반하는 산소 센서가 구비된 캡슐화 장치 시스템 |
WO2018102077A2 (en) | 2016-11-03 | 2018-06-07 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Methods, systems, and implantable devices for enhancing blood glucose regulation |
US11052230B2 (en) | 2016-11-08 | 2021-07-06 | W. L. Gore & Associates, Inc. | Implantable encapsulation devices |
MX2019005676A (es) | 2016-11-15 | 2019-09-10 | Giner Life Sciences Inc | Dispositivo percutáneo de difusión de gases adecuado para su uso con un implante subcutáneo. |
US20170173262A1 (en) | 2017-03-01 | 2017-06-22 | François Paul VELTZ | Medical systems, devices and methods |
US20180298343A1 (en) | 2017-04-12 | 2018-10-18 | Arunthathy Sivakumaran | Compositions and methods for a three dimensional ex-vivo glomerular cell co-culture biological engineering model |
EP3618916A4 (en) | 2017-05-04 | 2021-04-14 | Giner Life Sciences, Inc. | ROBUST IMPLANTABLE GAS DISPENSING DEVICE AND PROCEDURES, SYSTEMS AND DEVICES THEREFORE |
-
2017
- 2017-11-03 KR KR1020197015935A patent/KR102460406B1/ko active IP Right Grant
- 2017-11-03 SG SG10202104562TA patent/SG10202104562TA/en unknown
- 2017-11-03 CN CN202211726312.1A patent/CN116919648A/zh active Pending
- 2017-11-03 US US16/347,388 patent/US11446133B2/en active Active
- 2017-11-03 CA CA3042709A patent/CA3042709A1/en active Pending
- 2017-11-03 AU AU2017396753A patent/AU2017396753B2/en active Active
- 2017-11-03 CN CN201780081104.1A patent/CN110121311B/zh active Active
- 2017-11-03 WO PCT/US2017/060034 patent/WO2018144098A1/en unknown
- 2017-11-03 KR KR1020227037085A patent/KR20220149620A/ko not_active Application Discontinuation
-
2021
- 2021-07-21 AU AU2021206840A patent/AU2021206840B2/en active Active
-
2022
- 2022-09-02 US US17/902,689 patent/US20230000612A1/en active Pending
-
2023
- 2023-08-30 AU AU2023222895A patent/AU2023222895A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2017396753B2 (en) | 2021-04-29 |
CN110121311B (zh) | 2023-01-06 |
AU2023222895A1 (en) | 2023-09-14 |
WO2018144098A1 (en) | 2018-08-09 |
US11446133B2 (en) | 2022-09-20 |
CN110121311A (zh) | 2019-08-13 |
AU2021206840B2 (en) | 2023-06-22 |
US20230000612A1 (en) | 2023-01-05 |
KR102460406B1 (ko) | 2022-10-31 |
AU2017396753A1 (en) | 2019-06-20 |
AU2021206840A1 (en) | 2021-08-12 |
US20200281709A1 (en) | 2020-09-10 |
KR20190106995A (ko) | 2019-09-18 |
CN116919648A (zh) | 2023-10-24 |
SG10202104562TA (en) | 2021-06-29 |
CA3042709A1 (en) | 2018-08-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102460406B1 (ko) | 산소 전달을 수반 또는 비-수반하는 적층형 조직 캡슐화 장치 시스템 | |
KR102436392B1 (ko) | 혈당 조절을 강화하기 위한 방법, 시스템 및 이식 장치 | |
KR20230037059A (ko) | 외부 산소 전달을 수반 또는 비-수반하는 산소 센서가 구비된 캡슐화 장치 시스템 | |
CN110267526B (zh) | 用于在移植前后实时评估包封装置中细胞的方法和系统 | |
ES2650496T3 (es) | Aparato de transporte de oxígeno a células implantadas | |
JP2008521538A (ja) | 移植可能な器具 | |
CN108882697A (zh) | 向移植细胞提供氧气的系统和方法 | |
US20150320836A1 (en) | Cryopreservation of cells inside a macro-encapsulation device | |
US20220134074A1 (en) | Methods and systems for encapsulation devices for housing cells and agents | |
EP3534835A1 (en) | Stacked tissue encapsulation device systems with or without oxygen delivery |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A107 | Divisional application of patent | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |